The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, and prednisone against the current standard-of-care in patients with ...
Amina Nurmammadova, an Azerbaijani PhD student at the MD Anderson Cancer Center Graduate School of Biomedical Sciences, ...
At the New Mexico Cancer Center in Albuquerque, groundbreaking treatments and compassionate care are helping change the lives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback